The introduction of highly active antiretroviral therapy (HAART) has caused a marked reduction in the occurrence and severity of parasitic infections, including the toxoplasmic encephalitis (TE). These changes have been attributed to the restoration of cell-mediated immunity. This study was developed to examine the activity of six antiretroviral protease inhibitors (API) on Toxoplasma gondii tachyzoites. The six API showed anti-Toxoplasma activity, with IC50 value between 1.4 and 6.6 µg/mL. Further studies at the molecular level should be performed to clarify if the use of API could be beneficial or not for AIDS patients with TE.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s0036-46652013000100012 | DOI Listing |
Publication Analysis
Top Keywords
protease inhibitors
8
toxoplasma gondii
8
antiretroviral activity
4
activity protease
4
inhibitors toxoplasma
4
gondii introduction
4
introduction highly
4
highly active
4
active antiretroviral
4
antiretroviral therapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!